Alessandra Lissoni

Dr. Alessandra Lissoni

Vita e Salute San Raffaele University, Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
SASilvio Abati
Silvio Abati
CBChiara Bramati
Chiara Bramati
SBStefano Bondi
Stefano Bondi
Alessandra LissoniAlessandra Lissoni
Alessandra Lissoni
Matteo TrimarchiMatteo Trimarchi
Matteo Trimarchi
Oral cancer (OC) is an uncommon malignancy in Western countries, being one of the most common cancers in some high-risk areas of the world. It is a largely preventable cancer, since most of the different risk factors identified, such as tobacco use, alcohol consumption, and betel nut chewing, are behaviors that increase the likelihood of the disease. Given its high mortality, early diagnosis is of utmost importance. Prevention and the anticipation of diagnosis begin with identification of potentially malignant lesions of the oral mucosa and with local conditions promoting chronic inflammation. Therefore, every lesion must be recognized promptly and treated adequately. The clinical recognition and evaluation of oral mucosal lesions can detect up to 99% of oral cancers/premalignancies. As stated by the World Health Organization, any suspicious lesion that does not subside within two weeks from detection and removal of local causes of irritation must be biopsied. Surgical biopsy remains the gold standard for diagnosis of oral cancer. Adjunctive tools have been developed and studied to help clinicians in the diagnostic pathway, such as toluidine blue vital staining and autofluorescence imaging. In the near future other methods, i.e., identification of salivary markers of progression may help in reducing mortality due to oral cancer.

Francesca LallaFrancesca Lalla
Francesca Lalla
Alessandro VinciguerraAlessandro Vinciguerra
Alessandro Vinciguerra
Alessandra LissoniAlessandra Lissoni
Alessandra Lissoni
GAGianluigi Arrigoni
Gianluigi Arrigoni
FLFrancesca Lira Luce
Francesca Lira Luce
SASilvio Abati
Silvio Abati
Solitary plasmacytoma (SP) is a rare malignant tumor of plasma cells with no systemic spread; however, when it disseminates and affects multiple skeletal sites, it is called multiple myeloma (MM). The etiology of solitary plasmacytoma is unknown, with two possible subtypes: solitary extramedullary plasmacytoma (EMP) and solitary bone plasmacytoma (SBP). We present a case of EMP arising as asymptomatic erythroplakia of the palate, which is rarely described in the literature. The definitive diagnosis was obtained with immunohistochemical studies, after which the lesion was subjected to excisional biopsy. At present, after two years of close follow-up, the patient has shown no signs of relapse or conversion to MM. The uniqueness of the case highlights the possibility of an atypical EMP lesion in the head and neck, thus posing a diagnostic and therapeutic challenge for physicians.

SBStefano Bondi
Stefano Bondi
Alessandro VinciguerraAlessandro Vinciguerra
Alessandro Vinciguerra
Alessandra LissoniAlessandra Lissoni
Alessandra Lissoni
NRNathalie Rizzo
Nathalie Rizzo
DBDiego Barbieri
Diego Barbieri
SASilvio Abati
Silvio Abati
Mucosal melanomas of the head and neck region are uncommon pathologies that can affect the oral cavity, and are characterized by a high rate of mortality. Considering the lack of knowledge regarding risk and prognostic factors, current best clinical practice is represented by a large surgical excision with disease-free margins, eventually associated with a reconstructive flap. Indeed, given the frequent necessity of postoperative radiotherapy and fast healing process, a reconstruction of the surgical gap is advisable. Even if several flaps have been most commonly used, the submental island flap represents a valid alternative thanks to local advantages and similar oncologic outcomes compared to free flaps.

1 January 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
MMMattia Moretti
Mattia Moretti
Alessandra LissoniAlessandra Lissoni
Alessandra Lissoni
GGGiorgio Gastaldi
Giorgio Gastaldi
GAGianluigi Arrigoni
Gianluigi Arrigoni
CDClaudio Doglioni
Claudio Doglioni
SASilvio Abati
Silvio Abati
Aim. Keratotic lesions, histologically classified as areas of hyperorthokeratosis and hyperparakeratosis, are the most recurrent clinical finding in the oral cavity. Their etiology is various, but frequently the cause is due to the friction against sharp dental edges and incongruous prostheses and also parafunctional habits might play a role as well. However, other inflammatory diseases such as oral lichen planus and lichenoid reactions have the clinical appearance of keratoses. Hexokinase II is an enzyme that is capable to phosphorylate glucose to produce glucose-6-phosphate, representing the first step in most of the glucose metabolic pathways and it is expressed mainly in insulin-dependent tissues such as skeletal muscle, cardiac muscle, and fatty tissues. This enzyme can bind to the outer mitochondrial membrane, modulating the inflammatory response and anti-apoptotic effects, in favor of the cell survival, especially in cancer cells. Materials and Methods. This study has been performed in a cohort of 35 patients, afferent the Oral Medicine and Oral Pathology Unit, Dept. of Dentistry, San Raffaele Hospital Milano, showing a clinical lesion compatible with keratosis. In order to confirm the objective and clinical diagnosis of the oral medicine expert, after obtaining an informed consent, incisional biopsies were performed, following the 14 days-rule. The specimens were routinely processed by the pathologist in order to highlight the presence of any sign of chronic lichenoid inflammation that presented the typical lymphocytic band aspect in the submucosa. Serial sections from the samples were dyed with the immunohistochemical technique using the streptavidin-peroxidase method and monoclonal antibodies anti-HK II (GeneTex, CA USA). The staining intensity was classified as 0,1,2,3 for respectively no staining, weak, moderate and strong intensity by two observers, that analyzed independently the cellular pattern of expression to exclude any possible bias before conveying to the final evaluation. Statistical analysis was performed using a JMP 9.01 software, using the Pearson Chi-square, and whereas it was possible, the Fischer's exact test. Results. The pathologic examination allowed the stratification of the samples by the presence of the chronic inflammation as follow: 22 keratotic lesions associated with chronic lichenoid infiltrate (62.86%) and 15 keratoses without (37.14%). Analyzing the staining intensity of HK II in those groups it was possible to underline some interesting findings; for the lesions characterized by inflammatory elements the staining was: absent in 1 out of 22 (4.55%), weak in 6 out of 22 (27.27%), moderate in 13 out of 22 (59.09%) and strong in 2 out of 22 (9.09%). On the counterpart, in the lesions without inflammation, the staining was absent in 6 out of 13 (46,16%), weak in 4 out of 13 (30.77%), moderate in 2 out of 13 (15.38%) and intense in 1 out of 13 (7.69%). These data entail a statistically significant difference in the staining intensity of HK II between the keratotic lesions with and without inflammation (p= 0.0130). Moreover, we proceeded to evaluate the patterns of expression of HK II that was localized more frequently in the cytoplasm of the epithelium cells. This expression was confirmed by the granular aspect of the dye that further suggested the well-known association with specific mitochondrial structures. However, it was also evidenced the peri-nuclear pattern of HK II in some tissutal elements. These characteristics have been evaluated in the two groups with the following results: in the lesions without inflammation, 1 sample out of 22 was not assessable (4.55%) because the dye wasn't present. 11 lesions out of 22 (50%) presented an expression just at the cytoplasmic level while 10 out of 22 (45.45%) showed some elements with peri-nuclear expression whereas, in the inflammatory lesions, 6 lesions out 13 were not assessable (46.15%) because the dye wasn't present. 4 lesions out of 13 (30.77%) showed a cytoplasmic pattern and 3 lesions out 13 (23.08%) had a peri-nuclear pattern too. These data revealed a statistical significance between the two groups (p=0.0118). Discussion. The major marker's expression of glucose metabolism as HK II in the keratoses with an inflammatory substrate is an important finding: the evidence-based literature did not report any proof about the role of this enzyme in the inflammatory diseases of the oral mucosa. One of the supposed causes could be the increased energetic supply typical of the tissues stressed by an inflammatory stimulus. Furthermore, this enzyme is overexpressed in many of the human neoplasms, including the oral squamous cell carcinoma (OSCC). This could suggest a predominant role of inflammation in the oral carcinogenesis as already evidenced in other districts: in 4 out of 22 hyperkeratotic lesions associated with inflammation, (18.18%) there were dysplastic alterations, while dysplasia was observed only in 1 out of 13 keratoses without inflammation (7.69%). The inflammatory response involves the vascular, connective and epithelial structures leading to a local hypoxia. The enzyme HIF-1 (Hypoxia-Inducible Factor 1) induce the hyperexpression of proteins such as HK II involved in the glycolysis and cell survival. Moreover, it is involved as well in the regulation of inflammatory pathways through its action on the glucose metabolism. In fact, elevated levels of glucose could activate specific pro-inflammatory responses. To confirm the role of hypoxia it is remarkable to report the results of the expression of cellular patterns of HK II: the peri-nuclear pattern, that is prevalent in inflammatory lesions could be the epiphenomenon of a mitochondrial peri-nuclear clustering, due to the association between hexokinase and mitochondrial structures as previously investigated into an animal study. The mitochondrial clustering is essential for the transcription of genes connected with hypoxia. Consequently,...

5 August 2025 in Clinical and Experimental Dental Research
Verified
Journal Article
Open access
ESEmilio Salerno
Emilio Salerno
SASilvio Abati
Silvio Abati
GAGianluigi Arrigoni
Gianluigi Arrigoni
DFDaniela Finocchiaro
Daniela Finocchiaro
GGGiorgio Gastaldi
Giorgio Gastaldi
Matteo TrimarchiMatteo Trimarchi
Matteo Trimarchi
Objectives: The primary objective of this study is to report and analyze two rare cases of secretory carcinoma (SC) of the minor salivary glands, focusing on their diagnostic and therapeutic work‐up. The study aims to enhance scientific knowledge about SC, which is crucial for developing targeted therapies and ensuring precise diagnosis, especially differentiating it from acinic cell carcinoma (ACC). Materials and Methods: The study involved a detailed examination of two patients diagnosed with SC of the minor salivary glands. Clinical examinations, histological investigations, and immunohistochemical analyses were conducted. The treatment approach included surgical excision of the lesions followed by regular follow‐ups to monitor for recurrence. Immunohistochemical analysis was performed to identify the presence of markers such as GATA3, SOX‐10, NTRK, mammaglobin, and others. Results: Two cases are shown: a case of a 76‐year‐old male with a lesion in the hard palate was initially misdiagnosed as leukoplakia. After surgical excision and histological examination, the lesion was identified as SC. The patient underwent follow‐up examinations, including MRI and CT scans, which showed no recurrence, and another case of a 39‐year‐old female with a nodule in the superior left vestibule underwent surgery to remove the nodule. Histological and immunohistochemical analyses confirmed SC, showing a high proliferation index and presence of the ETV6–NTRK3 gene fusion. Follow‐up imaging showed no signs of disease recurrence. Conclusions: The study underscores the importance of precise diagnosis and differentiation of SC from ACC. Surgical excision followed by regular monitoring is effective in managing SC. Immunohistochemical and molecular analyses are crucial for accurate diagnosis. The findings contribute to the growing body of evidence on SC and highlight the potential for developing more targeted therapies. Further research is needed to establish clear guidelines for follow‐up duration and treatment protocols.

1 January 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
BMBeatrice Mainardi
Beatrice Mainardi
Alessandra LissoniAlessandra Lissoni
Alessandra Lissoni
LCLetizia Carenzi
Letizia Carenzi
MSMaria Teresa Sberna
Maria Teresa Sberna
FPFilippo Pirani
Filippo Pirani
SASilvio Abati
Silvio Abati
Aim. Mouthwashes are usually liquid solutions held passively or swilled around the mouth. They are generally intended to prevent or treat oral infections and excess of oral biofilms reducing the microbial load in the oral cavity. Mouthwashes can be administrated also for their analgesic, anti-inflammatory or anti-fungal action or cosmetic action to control bad breath or as saliva substitutes in patients with xerostomia. Besides to the stabilizers and preservatives, many active ingredients have been used to obtain the curative and preventative effects in mouthwashes: essential oils, fluorides, antiseptic compounds, anti-inflammatory drugs, fluorides. Historically and recently many plants extracts have proposed and investigated as active ingredients of mouthwashes with variable results. The aim of this report is to present the results of a preliminary investigation of the effects of a new mouthwash proprietary formula containing selected natural ingredients in active concentrations: tea tree oil i.e. Melaleuca Alternifolia extract, Centella Asiatica extract, enzymes such as papain, dextranase, and lysozyme, the Idebenone antioxidant in a special viscous and bioadhesive vehicle with natural carrageenans and xanthan gum. The mouthwash is claimed to have a strong antibacterial and antifungal activity and anti-inflammatory properties together with a mucosal lubricating effect for its physical characteristics; due to its content this commercial product is claimed to reintegrate the natural defenses of the mouth, providing daily protection to gingiva and oral mucosa and promoting the balance of the oral ecosystem. Materials and Methods. a small cohort of 23 patients has been selected to assess the soothing and lubricating properties of the commercial mouthwash (LionelloBio QUIET® - OralItaly - Milano, Italy) to prevent and relieve any further oral dryness and discomfort. The cohort was represented by 17 females and 6 males with an age range from 30 to 79 years old, and a mean age of 60.7 with a standard deviation of 13.5. The oral diseases and conditions affecting the cohort were xerostomia, burning mouth disease (BMS), oral candidiasis, oral lichen planus and autoimmune disorders represented by membrane mucous pemphigoid (MMP). These inflammatory conditions were selected after the claim of the mouthwash, that has anti-inflammatory and antibacterial properties, due to its own active ingredients and natural extracts. Results. After a 1-month period, the patients were recalled and the oral lesions and conditions reevaluated. Out of the 23 patients, 3 of them did not show up to the appointment. The effects on xerostomia improvement, taste of the mouthwash and soothing effects were consistent for 18 patients out of 23 (78.3%), while just 2 patients did not find any relief or palatability (8.7%). The 13 patients of the cohort (56.5%) affected by oral lichen planus (5 patients) and with vesicular bullous lesions caused by the pemphigoid (3 patients) had a visible oral condition improvement and a quality of life noticeable upgrading. The other oral lesions were 2 patients with aphthous conditions, one patient with lichenoid lesions and a generalized gingivitis. Discussion. The mouthwash showed clearly a soothing and calming effect with the patients complaining about xerostomia and BMS and had a visible improvement on the reticular lesions and bullae of the patients affected by inflammatory and autoimmune diseases. This success is due to the components and ingredients that have been studied and reported in the scientific literature for their anti-inflammatory effects. Although their properties as anti-microbial agents are still debated and require further investigation, their action, especially on xerostomic patients, is favorable. Lysozyme and Melaleuca alternifolia extracts enhance the natural defenses of the oral cavity against microbes and preventing caries and gingival inflammation. Dextranase fights the bacterial adhesion and preventing the build-up of biofilm and debris. Centella Asiatica speeds up the healing processes and keeps a good balance of the local micro-circulation, reducing the pain and discomfort of gingival edema. The mouthwash has a viscous consistency that promotes its action inside the oral cavity since it is not washed out completely after spitting. The numbers obviously represent a small cohort but it should be considered as a good starting point for a more in-depth study.